KEGG Orthology (KO) [BR:ko00001]
09100 Metabolism
09111 Xenobiotics biodegradation and metabolism
00980 Metabolism of xenobiotics by cytochrome P450
K17685 CYP2A13; cytochrome P450 family 2 subfamily A13
09160 Human Diseases
09161 Cancer: overview
05204 Chemical carcinogenesis - DNA adducts
K17685 CYP2A13; cytochrome P450 family 2 subfamily A13
09180 Brite Hierarchies
09181 Protein families: metabolism
00199 Cytochrome P450
K17685 CYP2A13; cytochrome P450 family 2 subfamily A13
Enzymes [BR:ko01000]
1. Oxidoreductases
1.14 Acting on paired donors, with incorporation or reduction of molecular oxygen
1.14.14 With reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen into the other donor
1.14.14.1 unspecific monooxygenase
K17685 CYP2A13; cytochrome P450 family 2 subfamily A13
Cytochrome P450 [BR:ko00199]
Cytochrome P450, animal type
CYP2 family
K17685 CYP2A13; cytochrome P450 family 2 subfamily A13
Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.